Wegovy vs Compounded Semaglutide: What to Know

Same Active Ingredient, Different Products

Wegovy® and compounded semaglutide both contain semaglutide — the GLP-1 receptor agonist that has produced some of the most significant weight-loss outcomes in non-surgical clinical history. But they are not the same product, and the differences matter when you are deciding how to access treatment.

This guide gives you an honest, side-by-side comparison so you can have an informed conversation with your provider.

What Is Wegovy?

Wegovy® is Novo Nordisk's FDA-approved semaglutide product indicated for chronic weight management in adults with obesity or overweight with a weight-related health condition. It was approved in June 2021 at a maintenance dose of 2.4 mg weekly and is the version of semaglutide used in the landmark STEP clinical trial program.

STEP trial results were striking: participants on 2.4 mg semaglutide lost an average of 14.9% to 16.9% of body weight over 68 weeks — roughly 30 to 35 lbs for a 200-lb person. For the full breakdown of what these numbers mean in real terms, see our GLP-1 weight loss results guide.

Wegovy® is delivered in pre-filled, single-use injection pens in fixed doses (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg) that follow a standard 16-week titration schedule. The FDA-approved status means it has been evaluated for safety, efficacy, and manufacturing quality under strict regulatory standards.

The trade-off is cost. Without insurance coverage, Wegovy® typically runs $1,350 to $1,450 per month — a figure that puts it out of reach for the majority of Americans paying out of pocket.

What Is Compounded Semaglutide?

Compounded semaglutide is a customized preparation of semaglutide made by a state-licensed compounding pharmacy in response to a valid prescription from a licensed healthcare provider. It is different from FDA-approved branded products such as Wegovy® and Ozempic® and has not been evaluated by the FDA for safety, efficacy, or quality. Formulation, inactive ingredients, and clinical characteristics may differ from the FDA-approved branded versions.

Compounding became a legal pathway when semaglutide appeared on the FDA's drug shortage list — a period during which demand dramatically outpaced Novo Nordisk's manufacturing capacity. Under federal law, licensed compounding pharmacies may prepare customized versions of a drug during a declared shortage to help meet patient need. The result: patients gained access to the same active ingredient at a fraction of the brand-name price. For a complete explanation of the legal and regulatory framework, see our compounded semaglutide guide.

Side-by-Side Comparison

Active Ingredient

Both: semaglutide. The core mechanism — GLP-1 receptor activation, appetite suppression, slowed gastric emptying, and reduced food cravings — relies on the same molecule.

FDA Regulatory Status

Wegovy: FDA-approved; evaluated for safety, efficacy, and manufacturing quality. Every batch is produced under FDA-regulated standards with documented quality control.
Compounded semaglutide: Not FDA-approved; not evaluated by the FDA. Reputable compounding pharmacies work under strict sterile-compounding standards and source pharmaceutical-grade active ingredients with third-party batch testing — but this is not FDA oversight. Quality varies by pharmacy.

Cost

Wegovy (no insurance): approximately $1,350–$1,450 per month.
Compounded semaglutide: typically $150–$350 per month through a licensed telehealth provider. See AvataCore pricing → for current program details.

Dosing and Administration

Wegovy: pre-filled single-use injection pens in fixed doses. No measurement required.
Compounded semaglutide: typically supplied in multi-dose vials, with patients drawing each weekly dose using a small insulin syringe. The process is straightforward once learned. Our step-by-step self-injection guide walks through it in full.

Insurance Coverage

Wegovy: covered by some commercial insurance plans, subject to prior authorization, step therapy requirements, and inconsistent plan-to-plan decisions. Many insured patients still face denials or significant cost-sharing.
Compounded semaglutide: cash-pay only; not reimbursable by insurance. The lower base cost makes the cash-pay route accessible for most patients who would pay out of pocket for Wegovy anyway.

What the Clinical Evidence Covers

The clinical effectiveness data for semaglutide at weight-loss doses — including the STEP trial results — comes from studies using the brand-name Wegovy® formulation. Because compounded semaglutide uses the same active ingredient at equivalent doses, providers reference this data when discussing expected outcomes, but the compounded formulation itself has not been independently validated in randomized controlled trials. This is a meaningful distinction to understand before starting treatment.

How Compounding Pharmacies Ensure Quality

Not all compounding pharmacies are equal. AvataCore partners exclusively with state-licensed compounding pharmacies that operate under sterile-compounding quality standards (USP 797/800), prepare medications only in response to valid prescriptions from licensed providers, source active pharmaceutical ingredients from DEA-registered, FDA-inspected suppliers, and perform independent third-party testing for potency, sterility, and endotoxins on every batch. These standards are not the same as FDA approval, but they represent a meaningful quality baseline for compounded preparations.

Who Benefits Most From Each Option

Wegovy® is the logical choice for patients who have qualifying insurance coverage with manageable cost-sharing — and for patients who prefer the simplicity of pre-filled, FDA-approved pens and the full weight of regulatory quality assurance behind their medication.

Compounded semaglutide through a licensed telehealth provider is the practical route for the majority of weight-loss patients who are cash-pay, whose insurance does not cover Wegovy, or who face prior authorization barriers. The meaningful cost difference — often $1,100+ per month — is the dominant factor for most people making this decision.

If you are also weighing whether semaglutide or tirzepatide is the better fit for your goals, our head-to-head comparison guide covers clinical differences, trial data, and side effect profiles in detail. For a detailed look at semaglutide pricing across all access routes, see our complete semaglutide cost guide.